NewcelX

NewcelX Debt/EBITDA

The Total Debt to EBITDA Ratio of NewcelX (NCEL) as of Nov 14, 2026 is -0.14. In the previous year, Total Debt to EBITDA Ratio was -0.14 — a change of 3.70% (lower).

Debt/EBITDA

-0.14

YoY

3.70%

Last updated:

Total Debt to EBITDA Ratio of NewcelX is 2025 -0.14 . Total Debt to EBITDA Ratio of NewcelX was 2024 -0.14 . It decreases by 3.70% lower compared to the previous year.

The NewcelX Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2017
-1.54 USD
Jan 1, 2018
-2,056.68 USD
Jan 1, 2019
-0.20 USD
Jan 1, 2020
-0.91 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
-0.14 USD
Jan 1, 2025
-0.14 USD
The NewcelX Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.14+3.70%
-0.14—
0.00-100.00%
-0.91+351.88%
-0.20-99.99%
-2,056.68+133,651.68%
-1.54—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NewcelX Stock analysis

What does NewcelX do? NewcelX AG, based in Zurich, Switzerland, operates in the Health Care sector with a focus on Pharmaceuticals. The company, listed on 29 January 2021, develops therapeutics for neurobehavioral and neurocognitive disorders. With a small team of two employees, it serves customers globally, concentrating on innovative treatments for neurological conditions. NewcelX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewcelX stock

Total Debt to EBITDA Ratio of NewcelX is -0.14 in 2025.

Total Debt to EBITDA Ratio of NewcelX changed from -0.14 to -0.14, representing a 3.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio NewcelX since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's NewcelX with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NewcelX

All Key Metrics — NewcelX